LIGAND PHARMACEUTICALS INCORPORATED Remaining Share Repurchase Authorization
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Remaining Share Repurchase Authorization of $50.00 million as of 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2024-11-08
- 2024-09-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $50.00M.
- 2024-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $50.00M.
- 2024-03-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $50.00M.
- 2023-09-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $50.00M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2024-09-30 | $50.00M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $50.00M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $50.00M 10-Q · filed 2024-05-08 |
| 2023-09-30 | $50.00M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $50.00M 10-Q · filed 2023-08-09 |
| 2022-09-30 | $248.80M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $248.80M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $248.80M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $248.80M 10-K · filed 2022-02-28 |
| 2021-09-30 | $248.80M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $248.80M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $248.80M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $248.80M 10-K · filed 2021-02-24 |
| 2020-09-30 | $253.50M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $253.50M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $253.50M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $326.80M 10-K · filed 2020-02-27 |
| 2019-09-30 | $408.70M 10-Q · filed 2019-11-08 |
| 2018-12-31 | $125.20M 10-K · filed 2019-02-28 |
| 2017-12-31 | $193.60M 10-K · filed 2018-03-01 |
| 2016-12-31 | $195.60M 10-K · filed 2017-02-28 |